Glycosaminoglycans (GAGs) were significantly altered in localized as well advanced RCC compared to healthy samples. In addition, GAG scores correlated with progression-free survival and overall survival (OS) in a prospective cohort of patients with metastatic ccRCC and localized RCC. However, it is still unknown whether alterations in plasma and urine GAGs are exquisitely specific to RCC or are shared by other benign lesions in the kidney, such as angiomyolipomas, oncocytomas, or PEComa.
Study Type
OBSERVATIONAL
Enrollment
200
Zealand University Hospital
Roskilde, Denmark
RECRUITINGTo identify the optimal GAG score
To identify the optimal GAG score in RCC patients
Time frame: 2 years
To identify the optimal GAG score
To identify the optimal GAG score in oncocytoma
Time frame: 2 years
To identify the optimal GAG score
To identify the optimal GAG score in healthy individuel
Time frame: 2 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.